Publications by authors named "T Kusakabe"

The gut mycobiota is crucial for intestinal homeostasis and immune function. Yet its variability and inconsistent fungal colonization of laboratory mice hinders the study of the evolutionary and immune processes that underpin commensalism. Here, we show that Kazachstania pintolopesii is a fungal commensal in wild urban and rural mice, with an exceptional ability to colonize the mouse gastrointestinal tract and dominate the gut mycobiome.

View Article and Find Full Text PDF

Despite known single-cell expression profiles in vertebrate retinas, understanding of their developmental and evolutionary expression patterns among homologous cell classes remains limited. We examined and compared approximately 240 000 retinal cells from four species and found significant similarities among homologous cell classes, indicating inherent regulatory patterns. To understand these shared patterns, we constructed gene regulatory networks for each developmental stage for three of these species.

View Article and Find Full Text PDF

Neural crest cells are multipotent progenitors that produce defining features of vertebrates such as the 'new head'. Here we use the tunicate, Ciona, to explore the evolutionary origins of neural crest since this invertebrate chordate is among the closest living relatives of vertebrates. Previous studies identified two potential neural crest cell types in Ciona, sensory pigment cells and bipolar tail neurons.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness of different screening tools (SARC-F, SARC-CalF, and calf circumference) for detecting sarcopenia in patients with osteoporosis, as early detection is important for reducing fall and fracture risks.
  • Conducted at Kyoto Medical Center, the research involved 225 patients, revealing a sarcopenia prevalence of 11.6%, with calf circumference showing the highest sensitivity and SARC-F showing the highest specificity.
  • Results indicate that SARC-CalF is the most reliable screening tool for identifying sarcopenia in these patients, highlighting its significance in clinical settings.
View Article and Find Full Text PDF
Article Synopsis
  • - A new vaccine called MAFB-7256a (DS-5670d) was developed in Japan and approved in Spring 2024 to prevent COVID-19, but there's currently no clinical efficacy data available for it.
  • - Researchers utilized a method called QASAS to assess the immune response of three healthy volunteers before and after they received the MAFB-7256a vaccination.
  • - The study found that B-cell receptor responses increased quickly one week after vaccination and then decreased, with antibodies specifically targeting the receptor-binding domain (RBD) of the virus, indicating the vaccine's focused immunogenicity.
View Article and Find Full Text PDF